Concourse Financial Group Securities’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2509 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4114 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4110 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4148 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4161 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4099 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4064 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4017 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3928 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3896 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3677 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3729 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3678 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3799 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3746 |
|